Behavioral Activation for Depression Through Virtual Reality

Universitat Jaume I0 sites8 target enrollmentDecember 5, 2021

ConditionsDepression

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Depression
Sponsor: Universitat Jaume I
Enrollment: 8
Primary Endpoint: Change in Behavioral activation
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Evaluate the effectiveness of a brief, virtual reality intervention for depressed mood

Registry

clinicaltrials.gov

Start Date

December 5, 2021

End Date

February 20, 2022

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Universitat Jaume I

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient Health Questionnaire - 9 (measure of depression) over 9
•Positive and Negative Affect Schedule (measure of positive and negative affect): positive affect score below 24
•Age over 18 years
•Signs informed consent

Exclusion Criteria

•Completes more than 20% of evaluations retrospectively (not the day they are assigned)
•Has a severe mental health disorder as evaluated with the MINI International Neuropsychiatric Interview
•Does not sign the informed consent

Outcomes

Primary Outcomes

Change in Behavioral activation

Time Frame: Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline vs posttreatment)

In a scale from 0 (not at all) to 6 (completely), "to what extent were you satisfied with what you did today?"

Secondary Outcomes

Change in Activity level(Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment))
Change in Depression(Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment))
Change in Mood(Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment))
Change in Positive affect(Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment))
Change in Negative affect(Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment))